Item 3. Quantitative and Qualitative Disclosures about Market Risk
0K characters. Original on sec.gov ·
Item 3. Quantitative and Qualitative Disclosures about Market Risk
For quantitative and qualitative disclosures about market risk affecting Teradyne, see Part II Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” in our Annual Report on Form 10-K filed with the SEC on February 19, 2026. There were no material changes in our exposure to market risk from those set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Previous: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations · Next: Item 4. Controls and Procedures